Brief: Synthaverse Terminates Distreptaza Deal With Symphar
March 11 (Reuters) - Synthaverse SA SVEP.WA :
* TERMINATES "DISTREPTAZA" MEDICINAL PRODUCT DISTRIBUTION
AND
PROMOTION DEAL WITH SYMPHAR
* REASON FOR TERMINATION IS VIOLATION OF MATERIAL TERMS OF
AGREEMENT BY SYMPHAR
Source text for Eikon: urn:newsml:reuters.com:*:nEM7HwnBxa
Further company coverage: SVEP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Synthaverse SA
See all newsBrief: Synthaverse EGM To Vote On Share Capital Increase Via Series X Share Issue
Brief: Synthaverse Gets 45 Mln Zloty Loan From Polish Agency For Enterprise Development For Debt Refinancing
Brief: Synthaverse Receives Registration Certificate For Onko BCG Product In Paraguay Under Partnership With Blau
Brief: Synthaverse H1 Net Loss At 6.4 Mln Zlotys
Brief: Synthaverse Gets Poland's GIF Decision Extending Manufacturing For New Immunological Products Facility